April 4th 2025
The yearly convention in New York City showcased new and emerging technologies and gave participating exhibitors a chance to unveil their strategies for the second half of the 2020s.
Pharma Supply Chains: Contingency Planning Not Yet a Priority, Survey Says
November 20th 2015UPS’ 2015 “Pain in the Chain” survey suggests that pharma companies are getting better at product protection, cold chain and regulatory compliance, but need to improve cost control and planning for unexpected events. Lack of transparency and “too many handoffs” remain major challenges.
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?
The global supply chain for bovine and porcine heparin and regulatory considerations are examined.